Dendreon's Phase I Results of APC8024 -- anti-HER-2 Therapeutic Vaccine Demonstrate Ongoing Clinical Benefit in Women with Advanced Metastatic Breast Cancer as reported at the American Society of Clinical Oncology 2003 Annual Meeting
|
Thank you for your prompt article submissiom. I just sent an e-mail to Linda Marker and Dr. Park I thought it was a good idea to introduce our site to these scienyists who may need a future vehicle to work with to link on to our site if the future success of the research permits.
|
All times are GMT -7. The time now is 10:04 PM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021